Tachycardia is a condition in which there is an increase in normal heart rate. Ventricular tachycardia is an in frequent and increase in heart beat that start from ventricles. Ventricles are lower chamber of the heart, which play a Vitol role in pumping of blood. The prolonged situation of ventricular tachycardia may lead to decrease in blood pressure, a condition called hypotension and sometimes it could be fatal.
Each year Ventricular Tachycardia and other cardiovascular disease (CVD) cause over 4 million deaths in Europe and over 1.9 million deaths in the European Union (EU).
Symptoms and Treatment
Symptoms of ventricular tachycardia includes, chest pain (angia), fainting, light headedness, shortness of breath, weak pulse. Treatment of ventricular tachycardia includes, medical therapy usually medication includes, beta blockers, calcium channel blockers, anti-arrhythmic medications such as amiodarone, sotalal or mexilentine.
Research on ventricular tachycardia is increasing year by a year. Emphasize has been done on the detection and diagnosis and cure of heart failure and other heart related diseases. Interdisciplinary cooperation and large scale studies comprise the basis for future oriented and patient oriented cardiovascular research. New research initiatives would benefit in the development of a risk prediction model.